We serve Chemical Name:(2-Thiomorpholin-4-ylpyridin-4-yl)methanol CAS:898289-25-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(2-Thiomorpholin-4-ylpyridin-4-yl)methanol
CAS.NO:898289-25-3
Synonyms:4-[4-(Hydroxymethyl)pyridin-2-yl]thiomorpholine;4-(Hydroxymethyl)-2-(thiomorpholin-4-yl)pyridine
Molecular Formula:C10H14N2OS
Molecular Weight:210.29600
HS Code:2934999090
Physical and Chemical Properties:
Melting point:102-104ºC
Boiling point:444.5ºC at 760 mmHg
Density:1.25g/cm3
Index of Refraction:1.62
PSA:61.66000
Exact Mass:210.08300
LogP:1.19210
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4-[4-(Hydroxymethyl)pyridin-2-yl]thiomorpholine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-(Hydroxymethyl)-2-(thiomorpholin-4-yl)pyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-(Hydroxymethyl)-2-(thiomorpholin-4-yl)pyridine Use and application,4-(Hydroxymethyl)-2-(thiomorpholin-4-yl)pyridine technical grade,usp/ep/jp grade.
Related News: Among the APIs we produce, there is an API which passes through over ten kinds of intermediates in a process when it changes from being a raw material into an API. (2-Thiomorpholin-4-ylpyridin-4-yl)methanol manufacturer AbbVie and Johnson & Johnson already boast three FDA-approved regimens for Imbruvica in newly diagnosed chronic lymphocytic leukemia (CLL). Now, the pair aims to add another to the drug’s label, one that could shorten the time patients need to stay on treatment. (2-Thiomorpholin-4-ylpyridin-4-yl)methanol supplier The unit of the British drugmaker, which is challenging HIV drug market leader Gilead Sciences, said it will work with the FDA to determine the next steps for the new drug application. (2-Thiomorpholin-4-ylpyridin-4-yl)methanol vendor Common signs of infection include respiratory symptoms, fever, cough, shortness of breath and breathing difficulties. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death. (2-Thiomorpholin-4-ylpyridin-4-yl)methanol factory AbbVie and Johnson & Johnson already boast three FDA-approved regimens for Imbruvica in newly diagnosed chronic lymphocytic leukemia (CLL). Now, the pair aims to add another to the drug’s label, one that could shorten the time patients need to stay on treatment.
